Table 2.
Differences in presentation of sign and symptoms between SARS-COV-2 positive and negative serologic test groups.
| Signs or symptoms | Seronegative group | Seropositive group | P value | Odds Ratio (95% Confidence Interval) |
|---|---|---|---|---|
| Fevera | 2.74% | 9.32% | 2.20 * 10−5 | 3.65 (1.93- 6.90) |
| Malaisea | 3.42% | 9.32% | 4.33 * 10−4 | 2.90 (1.56- 5.38) |
| Weaknessa | 2.22% | 9.32% | 1.00 * 10−6 | 4.52 (2.34–8.73) |
| Cough | 3.68% | 6.88% | 5.44 * 10−2 | 1.94 (0.98–3.83) |
| Red eye | 0.68% | 1.24% | 4.42 * 10−1 | 1.83 (0.39–8.68) |
| Diarrheaa | 1.11% | 3.73% | 8.71 * 10−3 | 3.45 (1.29–9.20) |
| Nauseaa | 0.34% | 1.86% | 4.21 * 10−2 | 5.54 (1.23–24.96) |
| Vomiting | 0.26% | 1.24% | 1.14 * 10−1 | 4.89 (0.81–29.51) |
| Runny nose | 2.83% | 4.35% | 2.89 * 10−1 | 1.56 (0.68–3.60) |
| Sore throat | 3.60% | 4.97% | 3.88 * 10−1 | 1.40 (0.65–3.05) |
| Headachea | 2.73% | 5.62% | 4.73 * 10−2 | 2.12 (0.99–4.53) |
| Dyspnea | 1.28% | 0.62% | 4.71 * 10−1 | 0.48 (0.63–3.67) |
| Chest pain | 1.03% | 1.86% | 4.12 * 10−1 | 1.83 (0.51–6.56) |
| Anosmiaa | 1.20% | 8.70% | 5.08 * 10−10 | 7.86 (3.68–16.82) |
| Ageusiaa | 0.85% | 8.07% | 4.37 * 10−11 | 10.19 (4.39–23.65) |
| Arthralgia | 0.51% | 1.24% | 2.51 * 10−1 | 2.44 (0.49–12.19) |
| Chillinga | 1.79% | 4.97% | 9.70 * 10−3 | 2.86 (1.25–6.57) |
| Skin symptoms | 0.34% | 0.62% | 4.76 * 10−1 | 1.82 (0.20–16.40) |
a
P value < 0.05